title: [Some clinical aspects of adult T-cell leukemia-lymphoma (ATLL) (3). Therapy of adult T-cell lymphoma].
authors.forename: K
authors.initials: K
authors.lastname: Kinoshita
authors.forename: S
authors.initials: S
authors.lastname: Ikeda
authors.forename: S
authors.initials: S
authors.lastname: Momita
authors.forename: H
authors.initials: H
authors.lastname: Soda
authors.forename: J
authors.initials: J
authors.lastname: Suzuyama
authors.forename: M
authors.initials: M
authors.lastname: Ichimaru
authors.forename: K
authors.initials: K
authors.lastname: Toriya
authors.forename: T
authors.initials: T
authors.lastname: Amamgasaki
authors.forename: S
authors.initials: S
authors.lastname: Kamihira
authors.forename: Y
authors.initials: Y
authors.lastname: Yamada
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols; D003520:Cyclophosphamide / Q000627:therapeutic use; D006800:Deltaretrovirus Infections / Q000188:drug therapy* / Q000401:mortality; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D007770:L-Lactate Dehydrogenase